Current challenges in cartilage tissue engineering: A review of current cellular-based therapies

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cellular-based therapies for cartilage tissue engineering have evolved quite significantly in the past decades. The realization that such an endeavor requires the acquisition of an adequate stem or progenitor cell population, techniques to effectively maintain or induce the desired phenotype and efficient culturing and implantation conditions have led researchers to develop a wide variety of protocols to approach the issue. Originally, cells taken from donor grafts of healthy cartilage were used as the cell source for tissue engineering constructs. Since then, however, researchers have moved on to cells from the adipose tissue, embryonic tissues, bone marrow and other sources. Similarly, as the potential for different cell sources to generate functional mesenchymal lineage tissues are discovered, several differentiation and phenotypic maintainance stimuli have been explored to optimize the resulting grafts. Physical stimuli in the form of mechanical compression as well as chemical stimuli in the form of growth factor cocktails have all proven effective in the induction of cells into the chondrogenic lineage to varying degrees. Finally, substrate expansion of these cells in materials ranging from naturally occuring ploymers such as fibrin, to synthetic and micro-fabricated structures is an active field of research. This review will discuss the most recent methods being utilized for the initiation of chondrogenesis from various stem cell sources as well as some methods being explored in our laboratory.

Original languageEnglish
Pages (from-to)8-14
Number of pages7
JournalCurrent Rheumatology Reviews
Volume5
Issue number1
DOIs
StatePublished - Jun 1 2009

Fingerprint

Tissue Engineering
Cartilage
Stem Cells
Therapeutics
Research Personnel
Transplants
Chondrogenesis
Fibrin
Adipose Tissue
Intercellular Signaling Peptides and Proteins
Bone Marrow
Phenotype
Research
Population

ASJC Scopus subject areas

  • Rheumatology

Cite this

Current challenges in cartilage tissue engineering : A review of current cellular-based therapies. / Fritz, Jason R.; Pelaez, Daniel; Cheung, Herman S.

In: Current Rheumatology Reviews, Vol. 5, No. 1, 01.06.2009, p. 8-14.

Research output: Contribution to journalArticle

@article{fe7d235ff87c47cca78c5eb42c7d8eb0,
title = "Current challenges in cartilage tissue engineering: A review of current cellular-based therapies",
abstract = "Cellular-based therapies for cartilage tissue engineering have evolved quite significantly in the past decades. The realization that such an endeavor requires the acquisition of an adequate stem or progenitor cell population, techniques to effectively maintain or induce the desired phenotype and efficient culturing and implantation conditions have led researchers to develop a wide variety of protocols to approach the issue. Originally, cells taken from donor grafts of healthy cartilage were used as the cell source for tissue engineering constructs. Since then, however, researchers have moved on to cells from the adipose tissue, embryonic tissues, bone marrow and other sources. Similarly, as the potential for different cell sources to generate functional mesenchymal lineage tissues are discovered, several differentiation and phenotypic maintainance stimuli have been explored to optimize the resulting grafts. Physical stimuli in the form of mechanical compression as well as chemical stimuli in the form of growth factor cocktails have all proven effective in the induction of cells into the chondrogenic lineage to varying degrees. Finally, substrate expansion of these cells in materials ranging from naturally occuring ploymers such as fibrin, to synthetic and micro-fabricated structures is an active field of research. This review will discuss the most recent methods being utilized for the initiation of chondrogenesis from various stem cell sources as well as some methods being explored in our laboratory.",
author = "Fritz, {Jason R.} and Daniel Pelaez and Cheung, {Herman S}",
year = "2009",
month = "6",
day = "1",
doi = "10.2174/157339709787315401",
language = "English",
volume = "5",
pages = "8--14",
journal = "Current Rheumatology Reviews",
issn = "1573-3971",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Current challenges in cartilage tissue engineering

T2 - A review of current cellular-based therapies

AU - Fritz, Jason R.

AU - Pelaez, Daniel

AU - Cheung, Herman S

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Cellular-based therapies for cartilage tissue engineering have evolved quite significantly in the past decades. The realization that such an endeavor requires the acquisition of an adequate stem or progenitor cell population, techniques to effectively maintain or induce the desired phenotype and efficient culturing and implantation conditions have led researchers to develop a wide variety of protocols to approach the issue. Originally, cells taken from donor grafts of healthy cartilage were used as the cell source for tissue engineering constructs. Since then, however, researchers have moved on to cells from the adipose tissue, embryonic tissues, bone marrow and other sources. Similarly, as the potential for different cell sources to generate functional mesenchymal lineage tissues are discovered, several differentiation and phenotypic maintainance stimuli have been explored to optimize the resulting grafts. Physical stimuli in the form of mechanical compression as well as chemical stimuli in the form of growth factor cocktails have all proven effective in the induction of cells into the chondrogenic lineage to varying degrees. Finally, substrate expansion of these cells in materials ranging from naturally occuring ploymers such as fibrin, to synthetic and micro-fabricated structures is an active field of research. This review will discuss the most recent methods being utilized for the initiation of chondrogenesis from various stem cell sources as well as some methods being explored in our laboratory.

AB - Cellular-based therapies for cartilage tissue engineering have evolved quite significantly in the past decades. The realization that such an endeavor requires the acquisition of an adequate stem or progenitor cell population, techniques to effectively maintain or induce the desired phenotype and efficient culturing and implantation conditions have led researchers to develop a wide variety of protocols to approach the issue. Originally, cells taken from donor grafts of healthy cartilage were used as the cell source for tissue engineering constructs. Since then, however, researchers have moved on to cells from the adipose tissue, embryonic tissues, bone marrow and other sources. Similarly, as the potential for different cell sources to generate functional mesenchymal lineage tissues are discovered, several differentiation and phenotypic maintainance stimuli have been explored to optimize the resulting grafts. Physical stimuli in the form of mechanical compression as well as chemical stimuli in the form of growth factor cocktails have all proven effective in the induction of cells into the chondrogenic lineage to varying degrees. Finally, substrate expansion of these cells in materials ranging from naturally occuring ploymers such as fibrin, to synthetic and micro-fabricated structures is an active field of research. This review will discuss the most recent methods being utilized for the initiation of chondrogenesis from various stem cell sources as well as some methods being explored in our laboratory.

UR - http://www.scopus.com/inward/record.url?scp=65949122104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949122104&partnerID=8YFLogxK

U2 - 10.2174/157339709787315401

DO - 10.2174/157339709787315401

M3 - Article

AN - SCOPUS:65949122104

VL - 5

SP - 8

EP - 14

JO - Current Rheumatology Reviews

JF - Current Rheumatology Reviews

SN - 1573-3971

IS - 1

ER -